Granville D J, Ruehlmann D O, Choy J C, Cassidy B A, Hunt D W, van Breemen C, McManus B M
UBC McDonald Research Laboratories and the iCAPTURE Centre/, St. Paul's Hospital ed.-University of British Columbia, Vancouver, BC, Canada.
Cell Calcium. 2001 Nov;30(5):343-50. doi: 10.1054/ceca.2001.0243.
Photodynamic therapy (PDT) is clinically approved for the treatment of several types of cancer as well as age-related macular degeneration, the leading cause of blindness in the elderly. PDT using the photosensitizer verteporfin has been previously shown to induce rapid apoptosis via a mitochondrial-caspase activation pathway. The impact of PDT on other cellular organelles such as the endoplasmic reticulum (ER) is undefined. The effect of PDT on intracellular Ca2+ ([Ca2+]i) in control and Bcl-2-overexpressing HeLa cells was assessed. A greater [Ca2+]i transient was observed for Bcl-2 overexpressing cells in response to PDT. The PDT-induced Ca2+ release was due to the emptying of Ca2+ from ER and possibly mitochondrial stores and was not due to an influx of Ca2+ from the medium. For Bcl-2-transfected cells, the release of Ca2+ was incomplete as determined by a further [Ca2+]i transient produced by the addition of the Ca2+ ionophore ionomycin after PDT. Furthermore, extrusion of Ca2+ was not hindered while ER-mediated sequestration of Ca2+ was impaired after PDT. Impairment of ER-mediated sequestration of Ca2+ may be due to the immediate caspase-independent depletion of sarco/endoplasmic reticulum Ca2+ ATPase-2 (SERCA2) that occurred in response to PDT in birth HeLa/Neo and Bcl-2 overexpressed HeLa cells. In summary, PDT induced the rapid degradation of SERCA2 and release of ER and mitochondrial Ca2+ stores. Although overexpression of Bcl-2 did not protect against SERCA2 degradation, it may influence the release of Ca2+ from ER and mitochondrial stores in PDT-treated cells.
光动力疗法(PDT)已获临床批准用于治疗多种癌症以及年龄相关性黄斑变性,后者是老年人失明的主要原因。先前已证明,使用光敏剂维替泊芬的光动力疗法可通过线粒体-半胱天冬酶激活途径诱导快速凋亡。光动力疗法对其他细胞器如内质网(ER)的影响尚不清楚。评估了光动力疗法对对照细胞和过表达Bcl-2的HeLa细胞内Ca2+([Ca2+]i)的影响。在过表达Bcl-2的细胞中,观察到对光动力疗法有更大的[Ca2+]i瞬变。光动力疗法诱导的Ca2+释放是由于内质网以及可能还有线粒体储存中的Ca2+排空,而不是由于Ca2+从培养基中流入。对于转染了Bcl-2的细胞,通过在光动力疗法后添加Ca2+离子载体离子霉素产生的进一步[Ca2+]i瞬变确定,Ca2+的释放是不完全的。此外,光动力疗法后Ca2+的外排未受阻碍,而内质网介导的Ca2+螯合受损。内质网介导的Ca2+螯合受损可能是由于在野生型HeLa/Neo细胞和过表达Bcl-2的HeLa细胞中,光动力疗法引起的肌浆网/内质网Ca2+ ATP酶-2(SERCA2)的立即非半胱天冬酶依赖性消耗。总之,光动力疗法诱导了SERCA2的快速降解以及内质网和线粒体Ca2+储存的释放。虽然Bcl-2的过表达不能防止SERCA2降解,但它可能会影响光动力疗法处理的细胞中内质网和线粒体储存中Ca2+的释放。